Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors | Zendy

Daniel Périard | Zendy; Amalio Telenti | Zendy; Philippe Sudre | Zendy; Jean-Jacques Cheseaux | Zendy; Patricia Halfon | Zendy; Marianne J. Reymond | Zendy; Santica M. Marcovina | Zendy; M. P. Glauser | Zendy; Pascal Nicod | Zendy; Roger Darioli | Zendy; Vincent Mooser | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

Author(s) -

Daniel Périard,

Amalio Telenti,

Philippe Sudre,

Jean-Jacques Cheseaux,

Patricia Halfon,

Marianne J. Reymond,

Santica M. Marcovina,

M. P. Glauser,

Pascal Nicod,

Roger Darioli,

Vincent Mooser

Publication year - 1999

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.100.7.700

Subject(s) - medicine , dyslipidemia , human immunodeficiency virus (hiv) , protease , virology , protease inhibitor (pharmacology) , antiretroviral therapy , viral load , disease , enzyme , biochemistry , chemistry

Administration of protease inhibitors (PIs) to HIV-infected individuals has been associated with hyperlipidemia. In this study, we characterized the lipoprotein profile in subjects receiving ritonavir, indinavir, or nelfinavir, alone or in combination with saquinavir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research